Natural product inhibitors of acetyl-lysine erasers in the prevention and treatment of heart failure

Loading...
Thumbnail Image

Authors

Evans, Levi W.
Romanick, Samantha S.
Ferguson, Bradley S.

Issue Date

2017

Type

Article

Language

en_US

Keywords

acetylation , bioactive compounds , dietary HDAC inhibitors , HDACs , histone deacetylases

Research Projects

Organizational Units

Journal Issue

Alternative Title

Abstract

Heart failure (HF) is a major public health concern, with five-year mortality rates following first admission for HF being approximately 50%, thereby stressing the need for novel therapeutic approaches. Histone deacetylases (HDACs) govern lysine acetylation of histone tails that regulates nucleosmal DNA. HDAC inhibitors have emerged as efficacious therapies in pre-clinical models of HF. Interest in diet-gene interactions has given rise to the study of 'food bioactives' as epigenetic regulators of gene expression that control human health and disease. These reports demonstrate that bioactive food compounds regulate epigenetic marks that link diet to gene regulation. In fact, others have also shown that bioactive compounds can target HDACs for inhibition
accordingly, bioactive food compounds offer unique opportunities for therapeutic intervention and prevention of heart failure. Lastly, there is emerging interest into how these food bioactives function together or as additives within foods 'functional foods' to regulate epigenetic disease. This review will highlight bioactive compound HDAC inhibitors and their role in the heart.

Description

Citation

Evans, L. W., Romanick, S. S., & Ferguson, B. S. (2017). Natural product inhibitors of acetyl-lysine erasers in the prevention and treatment of heart failure. Functional Foods in Health and Disease, 7(8), 577. doi:10.31989/ffhd.v7i8.376

Publisher

Functional Foods in Health and Disease

License

Journal

Volume

Issue

PubMed ID

ISSN

2160-3855

EISSN